4.4 Article

Lessons from Cost-Effectiveness Analysis of Smoking Cessation Programs for Cancer Patients

Related references

Note: Only part of the references are listed.
Editorial Material Oncology

Ignoring the Obvious: Smoking Cessation Improves Survival

William K. Evans et al.

JOURNAL OF THORACIC ONCOLOGY (2022)

Article Medicine, General & Internal

Cost-effectiveness of Implementing Smoking Cessation Interventions for Patients With Cancer

Douglas E. Levy et al.

Summary: This study estimated the incremental cost per quit of adopting an intensive smoking cessation intervention among patients undergoing treatment at cancer care clinics, finding that the implementation of the intensive smoking cessation treatment intervention was moderately to highly cost-effective, depending on existing smoking cessation services in place.

JAMA NETWORK OPEN (2022)

Article Oncology

Challenges and Adaptations for Providing Smoking Cessation for Patients with Cancer across Canada during the COVID-19 Pandemic

Graham W. Warren et al.

Summary: The COVID-19 pandemic disrupted smoking cessation support for cancer patients, but coordinated national efforts allowed for adaptations such as virtual support, maintaining or improving access to smoking cessation services during the crisis.

CURRENT ONCOLOGY (2022)

Article Oncology

Cost-Effectiveness of Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Simulation Study

Christopher J. Cadham et al.

Summary: This study compared the benefits and costs of different smoking cessation interventions in the context of lung cancer screening. The results showed that all cessation interventions reduced cases of and deaths from lung cancer. Efficient cessation strategies included pharmacotherapy combined with web-based, telephone, or individual counseling, with costs per QALY well below accepted thresholds.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Article Medicine, General & Internal

Characteristics of Cost-effectiveness Studies for Oncology Drugs Approved in the United States From 2015-2020

Alyson Haslam et al.

Summary: In this retrospective cross-sectional study, it was found that cost-effectiveness analyses funded by pharmaceutical companies were more likely to conclude that an oncology drug was cost-effective. This highlights the importance of independent cost-effectiveness analyses.

JAMA NETWORK OPEN (2021)

Article Psychiatry

Guidelines to understand and compute the number needed to treat

Valentin Vancak et al.

Summary: The software provides a user-friendly web application for calculating NNT in different settings and models. The application is illustrated using examples from schizophrenia research based on the Positive and Negative Syndrome Scale. Users can get the output in a journal compatible text format, which can be copied and pasted or downloaded in a comma-separated values format.

EVIDENCE-BASED MENTAL HEALTH (2021)

Editorial Material Oncology

Smoking Cessation After a Cancer Diagnosis Is Associated With Improved Survival

Graham W. Warren et al.

JOURNAL OF THORACIC ONCOLOGY (2020)

Article Public, Environmental & Occupational Health

Estimates of the current and future burden of cancer attributable to active and passive tobacco smoking in Canada

Abbey E. Poirier et al.

PREVENTIVE MEDICINE (2019)

Article Oncology

Implementing smoking cessation within cancer treatment centres and potential economic impacts

William K. Evans et al.

TRANSLATIONAL LUNG CANCER RESEARCH (2019)

Article Oncology

Economic evaluation of smoking cessation in Ontario's regional cancer programs

Sandjar Djalalov et al.

CANCER MEDICINE (2018)

Article Psychology, Clinical

Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists

Scott B. Cantor et al.

ADDICTIVE BEHAVIORS (2015)

Article Public, Environmental & Occupational Health

Who tended to continue smoking after cancer diagnosis: the national health and nutrition examination survey 1999-2008

Tung-Sung Tseng et al.

BMC PUBLIC HEALTH (2012)

Article Oncology

A Smoking Cessation Intervention for Thoracic Surgery and Oncology Clinics A Pilot Trial

Elyse R. Park et al.

JOURNAL OF THORACIC ONCOLOGY (2011)

Article Oncology

Cost-Effectiveness of a Smoking Cessation Program Implemented at the Time of Surgery for Lung Cancer

Christopher G. Slatore et al.

JOURNAL OF THORACIC ONCOLOGY (2009)